Fidelity Investments’s Co-Diagnostics CODX Stock Holding History

Fidelity Investments’s Portfolio CODX Stock Details CODX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-7	Closed	-$164	–	5355
2024 Q4	$164	Buy	+7	New	+$221	﹤0.01%	5067
2024 Q1	–	Sell	-25	Closed	-$1.01K	–	5409
2023 Q4	$1.01K	Sell	25 -1	-4%	-$35	﹤0.01%	4746
2023 Q3	$811	Buy	26 +1	+4%	+$38	﹤0.01%	4672
2023 Q2	$846	Sell	25 -181	-88%	-$6.93K	﹤0.01%	4739
2023 Q1	$9.15K	Buy	206 +152	+281%	+$12.2K	﹤0.01%	4160
2022 Q4	$4.07K	Buy	54 +29	+116%	+$2.71K	﹤0.01%	4322
2022 Q3	$2K	Hold	25	–	–	﹤0.01%	4530
2022 Q2	$4K	Hold	25	–	–	﹤0.01%	4362
2022 Q1	$5K	Buy	25 +8	+47%	+$1.66K	﹤0.01%	4419
2021 Q4	$4K	Sell	17 -5	-23%	-$1.31K	﹤0.01%	3848
2021 Q3	$6K	Buy	22 +11	+100%	+$3.21K	﹤0.01%	3727
2021 Q2	$3K	Buy	11 +8	+267%	+$2.06K	﹤0.01%	3825
2021 Q1	$1K	Buy	+3	New	+$1.2K	﹤0.01%	3814
2020 Q4	–	Hold	0	–	–	–	3869
2020 Q3	–	Hold	0	–	–	–	3713
2020 Q2	–	Hold	0	–	–	–	3651

Other funds holding CODX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAG

Private Advisory Group Redmond, Washington $1.52B AUM 41.01% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

Fidelity Investments's CODX Position: Q1 2025 in Review

Fidelity Investments sold out of Co-Diagnostics (CODX) in Q1 2025, closing a stake of 7 shares — an estimated $164 sold.

Fidelity Investments first reported a position in CODX in Q1 2021 and held it in 13 quarters. The position peaked at $9.15K in Q1 2023. 38 funds tracked by Wall St. Rank hold CODX as of Q1 2025.

Fidelity Investments reported no remaining Co-Diagnostics position as of Q1 2025 after selling out during the quarter.
Fidelity Investments sold 7 Co-Diagnostics shares in Q1 2025, an estimated $164.
Fidelity Investments first reported a position in Co-Diagnostics in Q1 2021 and held it in 13 quarters.
Fidelity Investments's Co-Diagnostics position peaked at $9.15K in Q1 2023.
38 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.